The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis

被引:50
作者
Chu, F [1 ]
Borthakur, A [1 ]
Sun, X [1 ]
Barkinge, J [1 ]
Gudi, R [1 ]
Hawkins, S [1 ]
Prasad, KVS [1 ]
机构
[1] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
apoptosis; BCL2; BCL-XL; BAX; caspase; 3; 9; cytochrome c; Siva; Siva-1; TNFR;
D O I
10.1023/B:APPT.0000012125.01799.4c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human Siva gene is localized to chromosome 14q3233 and gives rise to the full- length predominant form, Siva- 1 and a minor alternate form, Siva- 2 that appears to lack the proapoptotic properties of Siva- 1. Our recent work has shown that the missing region in Siva- 2 encodes a unique twenty amino acid putative amphipathic helical region ( SAH, residues 36 - 55 in Siva- 1). Despite the fact that Siva- 1 does not belong to the BCL- 2 family, it specifically interacts with the anti- apoptotic protein BCL-XL and sensitizes MCF7 breast cancer cells expressing BCL- XL to UV radiation induced apoptosis. Deletion mutagenesis has mapped the necessary region to the SAH in Siva- 1. In this paper we demonstrate that the SAH region in Siva- 1 is sufficient to specifically interact with the antiapoptotic members of the BCL2 family such as BCL- XL and BCL- 2 but not its apoptotic member BAX. Using transient transfections and direct microinjection of synthetic SAH peptides, we also demonstrate that the SAH region is sufficient to inhibit the BCL- XL mediated cell survival and render MDA- MB- 231 and MCF7 breast cancer cells expressing BCL- XL highly susceptible to UV radiation induced apoptosis. The underlying mechanism of action of SAH mediated inhibition of BCL- XL ( and/ or BCL2) cell survival appears to be due to loss of mitochondrial integrity as reflected in enhanced cytochrome c release leading to the activation of caspase 9 and finally caspase 3.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 49 条
[41]   Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein [J].
Sun, XM ;
Bratton, SB ;
Butterworth, M ;
MacFarlane, M ;
Cohen, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11345-11351
[42]   Tumor necrosis factor receptor and Fas signaling mechanisms [J].
Wallach, D ;
Varfolomeev, EE ;
Malinin, NL ;
Goltsev, YV ;
Kovalenko, AV ;
Boldin, MP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :331-367
[43]   Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells [J].
Wang, JL ;
Liu, DX ;
Zhang, ZJ ;
Shan, SM ;
Han, XB ;
Srinivasula, SM ;
Croce, CM ;
Alnemri, ES ;
Huang, ZW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7124-7129
[44]   BID: A novel BH3 domain-only death agonist [J].
Wang, K ;
Yin, XM ;
Chao, DT ;
Milliman, CL ;
Korsmeyer, SJ .
GENES & DEVELOPMENT, 1996, 10 (22) :2859-2869
[45]   TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes [J].
Xiao, H ;
Palhan, V ;
Yang, YL ;
Roeder, RG .
EMBO JOURNAL, 2000, 19 (05) :956-963
[46]   Siva-1 binds to and inhibits BCL-XL-mediated protection against UV radiation-induced apoptosis [J].
Xue, L ;
Chu, F ;
Cheng, Y ;
Sun, XJ ;
Borthakur, A ;
Ramarao, M ;
Pandey, P ;
Wu, M ;
Schlossman, SF ;
Prasad, KVS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6925-6930
[47]   Bax suppresses tumorigenesis and stimulates apoptosis in vivo [J].
Yin, CY ;
Knudson, CM ;
Korsmeyer, SJ ;
VanDyke, T .
NATURE, 1997, 385 (6617) :637-640
[48]   Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes [J].
Yin, XM .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (04) :203-211
[49]   Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis [J].
Yoon, Y ;
Ao, ZH ;
Cheng, Y ;
Schlossman, SF ;
Prasad, KVS .
ONCOGENE, 1999, 18 (50) :7174-7179